
An injection to prevent HIV is set to be approved for use in England and Wales.
The long-acting cabotegravir (CAB-LA) injection, administered every two months, will offer an alternative to the daily pills currently used to protect against the virus.

An injection to prevent HIV is set to be approved for use in England and Wales.
The long-acting cabotegravir (CAB-LA) injection, administered every two months, will offer an alternative to the daily pills currently used to protect against the virus.